Maha Osman Sulieman, MBBS

Maha Sulieman practices at Emory Saint Joseph's Hospital in Atlanta, Georgia, part of Emory University.

Maha Sulieman's NPI, 1013354943, was assigned on June 2, 2013. Maha Sulieman holds Georgia license 81324.

Maha Sulieman's primary practice is Emory Saint Joseph's Hospital, at 5665 Peachtree Dunwoody Road, Atlanta, GA 30342 in Fulton County. The practice phone is (678) 843-7001.

Maha Sulieman's primary practice is Emory Saint Joseph's Hospital in Atlanta, Georgia, part of Emory University. Maha Sulieman is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Maha Sulieman practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Maha Sulieman's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Maha Sulieman's licenses on file in 2 states: Georgia and Maryland.

CMS data shows 340 Medicare services from Maha Sulieman across 4 procedure codes in 2024, for 192 Medicare patients. Medicare paid $32,797 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Maha Sulieman in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Maha Sulieman's median patient age at 78, with 53% women.

In 2024, Maha Sulieman wrote 41 Medicare Part D claims for 28 patients. 98% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $6,666 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Maha Sulieman for performance year 2024, reported through an alternative payment model (APM). Maha Sulieman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Maha Sulieman, published from 2022 to 2025. Maha Sulieman's most frequent co-authors are Reem A. Ahmed, MD, Ronnye Christina Rutledge, MD and Samir S. Shah, MD.

CMS Open Payments shows 2 general payments to Maha Sulieman from 2 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $47.